Imcivree

Active Ingredient(s): Setmelanotide
FDA Approved: * November 25, 2020
Pharm Company: * RHYTHM PHARMACEUTICALS INC
Category: Diet / Weight Loss

Setmelanotide, sold under the brand name Imcivree, is a medication used for the treatment of genetic obesity.[1][2][3] The most common side effects include injection site reactions, skin hyperpigmentation (skin patches that are darker than surrounding skin), headache and gastrointestinal side effects (such as nausea, diarrhea, and abdominal pain), among others.[2] Spontaneous penile erections in males and adverse sexual reactions... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Imcivree 10 mg/ml Subcutaneous Solution
NDC: 72829-010
Labeler:
Rhythm Pharmaceuticals, Inc